Geneva, June 30 -- International Clinical Trials Registry received information related to the study (ACTRN12625000662460) titled 'A trial with healthy adult volunteers testing the effect of food on what happens to the drug emestedastat in the body' on June 23.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Open (masking not used)
Assignment: Crossover
Type of endpoint: Pharmacokinetics
Primary Sponsor: Actinogen Medical Ltd
Condition:
Alzheimer's Disease
Major depressive disorder
Alzheimer's Disease
Major depressive disorder
Neurological - Alzheimer's disease
Mental Health - Depression
Intervention:
emestedastat 10 mg oral tablet, 2 single doses, with a washout period ...